1. The European Commission has authorized expanded venetoclax (Venclyxto) combinations for previously untreated chronic lymphocytic leukemia. 2. The approval reinforces the continued movement toward fixed-duration, chemotherapy-free regimens in chronic lymphocytic...
Food Coloring Additives and Incidence of Type 2 Diabetes in the NutriNet-Santé Prospective Cohort 1. Several widely consumed natural and synthetic food coloring additives were associated with higher type 2...
1. The FDA has expanded the label for guselkumab (Tremfya) to include evidence that it can inhibit progression of structural joint damage in adults with active psoriatic arthritis. 2. Phase...
1. Pfizer has committed $650 million upfront in a collaboration with Innovent Biologics that could ultimately reach $10.5 billion in total value. 2. The agreement underscores the growing importance of...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
1. The EAST-AFNET 4 trial (East AF) demonstrated that early rhythm control therapy—including antiarrhythmic drugs or catheter ablation—was associated...
1. In this systematic review and meta-analysis, catheter ablation was found to reduce overall risk of ischemic stroke, hospitalization...
1. In this retrospective cohort study, breast cancer survivors had a lower risk of Alzheimer’s dementia compared with cancer-free...
1. For patients with facet-mediated spine pain that achieve ≥80% pain relief after a medial branch block, a second...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.